ESSA Pharma

About:

ESSA Pharma is a biotechnology company that develops new drugs for prostate cancer.

Website: http://www.essapharma.com

Twitter/X: essapharma

Top Investors: Pfizer, Deerfield, Biotechnology Value Fund, Silicon Valley Bank, Frazier Healthcare Partners

Description:

ESSA is a pharmaceutical company focused on the development of small molecule drugs for the treatment of cancer, with a focus on advanced prostate cancer. ESSA is developing drugs that selectively block the N-terminal domain of the androgen receptor (AR). The AR is required for the growth and survival of most prostate cancer; therefore, the AR N-terminal domain is an ideal target for next-generation hormone therapy.

Total Funding Amount:

$281M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2009-01-01

Contact Email:

info(AT)essapharma.com

Founders:

Marianne Sadar, Raymond Andersen

Number of Employees:

11-50

Last Funding Date:

2022-07-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai